New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells-Reference-Cited by-同舟云学术

New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells

Published:2021-10 Issue: Volume:115 Page:105208
ISSN:0045-2068
Container-title:Bioorganic Chemistry
language:en
Short-container-title:Bioorganic Chemistry

Author:

Farghaly Ahmed M.,AboulWafa Omaima M.,Baghdadi Hoda H.,Abd El Razik Heba A.,Sedra Samir M.Y.,Shamaa Marium M.

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Molecular Biology,Biochemistry

Reference82 articles.

1. Progress in the treatment of breast cancer;Konner;N. Engl. J. Med.,2020

2. Recent advances in the treatment of breast cancer;Tong;Front. Oncol.,2018

3. Current research on anti-breast cancer synthetic compounds;Liu;RSC Adv.,2018

4. Strategies to overcome acquired resistances conferred by mutations in the kinase domain of EGFR;Lim;Fut. Med. Chem.,2016

5. Recent updates on third generation EGFR inhibitors and emergence of fourth generation EGFR inhibitors to combat C797S resistance;Patel;Eur. J. Med. Chem.,2017

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fabrication of folic acid-conjugated pyrimidine-2(5H)-thione-encapsulated curdlan gum-PEGamine nanoparticles for folate receptor targeting breast cancer cells;International Journal of Biological Macromolecules;2024-10

2. Aromatase inhibitors for the treatment of breast cancer: An overview (2019–2023);Bioorganic Chemistry;2024-10

3. Synthesis and Transformations of Hydrazine-Substituted Pyrano[3″,4″:5′,6′]pyrido[3′,2′:4,5]thieno[3,2-d]pyrimidine;Журнал общей химии;2024-08-13

4. Design and one-pot synthesis of new substituted pyrrolo[1,2-a]thieno[3,2-e]pyrimidine as potential antitumor agents: in vitro and in vivo studies;Bioorganic Chemistry;2024-07

5. Identification of new 5-(2,6-dichlorophenyl)-3-oxo-2,3-dihydro-5H-thiazolo[3,2-a]pyrimidine-7-carboxylic acids as p38α MAPK inhibitors: Design, synthesis, antitumor evaluation, molecular docking and in silico studies;Bioorganic Chemistry;2024-04